News and Announcements
tagSpace Mixes up Reality – Delivers the first Global-scale Augmented Reality Publishing Platform
- Published January 11, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Ranked #3 Augmented Reality company in Australia by TechBoard
- Raised $1.75M to date
- 4 international patents filed, 2 published
- 12 new global expressions of interest since July 2017
- Mixed Reality browser apps released on iOS & Android app stores
- Mixed Reality authoring website MVP released
- Enterprise-grade Analytics Suite in development
2017 was a big growth year for tagSpace, they matured their mixed-reality technology platform and brought it to market, raised more capital, filed additional worldwide patents, staked their claim in the marketplace and set about finding early customers.
Mixed Reality is the fastest-growing new technology right now and set to hit over $220B in the next 4 years, already surpassing Virtual Reality. The biggest pain point for companies wishing to utilise these technologies however is the technology barrier-to-entry in creating mixed-reality applications and the enormous cost associated with creating and publishing content. tagSpace’s platform (called “tagStorm”) allows their customers to create Mixed Reality experiences without writing a single line of code or needing to create 3D graphics models themselves.
Gaining recognition as global leaders in Mixed Reality technologies, in July, tagSpace was ranked #3 augmented reality company in Australia by TechBoard (https://techboard.com.au/techboard-ranking-sector-spotlight-july-2017-augmentedvirtual-reality-companies/). Since then, they have received 12 expressions of interest with some of the world’s top brands, movie studios and event companies.
2018 is going to be busy for this company…
About tagSpace Pty Ltd
tagSpace offers a Platform-As-A-Service for Mixed Reality, an end-to-end solution for companies to create and place Mixed Reality content in real-world locations – quickly, cheaply and easily.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
